Physician profile
Ringo Leung
NPI 1629051024
$6,444.78
in general payments reported to CMS, 2019-2025
11 companies · $1,363 in 2025
The $1,363 reported for 2025 was more than what 97% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,051 · 2020: $56.09 · 2021: $110 · 2023: $2,036 · 2024: $829 · 2025: $1,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,369 · Gift: $1,106 · Education: $1,038 · Travel and Lodging: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.48 |
| Gift | $1,105.68 |
| Education | $1,037.50 |
| Travel and Lodging | $715.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $1,566.83 | 2019-2025 | |
| Dentsply Sirona INC | $1,439.39 | 2019-2025 | Astra Tech Implant System, Atlantis, Mis |
| A-Dec, INC. | $1,257.02 | 2023-2025 | |
| Sirona Dental, INC. | $750.00 | 2019 | |
| Ultradent Products INC | $621.63 | 2024-2025 | Opalescence |
| Nobel Biocare USA | $280.57 | 2019-2023 | Nobelactive |
| Biohorizons Implant Systems INC. | $201.03 | 2023-2024 | Biohorizons |
| Dentsply Ih INC. | $172.74 | 2019 | |
| Straumann USA LLC | $127.33 | 2024-2025 | |
| Glaxosmithkline, LLC. | $15.74 | 2024 | Rotarix, Bexsero, Pediarix |
| Hu-Friedy Mfg. Co., LLC | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ringo Leung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.